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Vancomycin-resistant Enterococcus faecium (VREfm) is a leading cause of healthcare-associated infection. Reservoirs of VREfm
are largely assumed to be nosocomial although there is a paucity of data on alternative sources. Here, we describe an inte-
grated epidemiological and genomic analysis of E. faecium associated with bloodstream infection and isolated from wastewa-
ter. Treated and untreated wastewater from 20 municipal treatment plants in the East of England, United Kingdom was
obtained and cultured to isolate E. faecium, ampicillin-resistant E. faecium (AREfm), and VREfm. VREfm was isolated from
all 20 treatment plants and was released into the environment by 17/20 plants, the exceptions using terminal ultraviolet
light disinfection. Median log10 counts of AREfm and VREfm in untreated wastewater from 10 plants in direct receipt of
hospital sewage were significantly higher than 10 plants that were not. We sequenced and compared the genomes of 423
isolates from wastewater with 187 isolates associated with bloodstream infection at five hospitals in the East of England.
Among 481 E. faecium isolates belonging to the hospital-adapted clade, we observed genetic intermixing between wastewater
and bloodstream infection, with highly related isolates shared between a major teaching hospital in the East of England and
9/20 plants. We detected 28 antibiotic resistance genes in the hospital-adapted clade, of which 23 were represented in
bloodstream, hospital sewage, and municipal wastewater isolates. We conclude that our findings are consistent with wide-
spread distribution of hospital-adapted VREfm beyond acute healthcare settings with extensive release of VREfm into the
environment in the East of England.
[Supplemental material is available for this article.]
Vancomycin-resistant Enterococcus faecium (VREfm) is a leading
cause of healthcare-associated infection and particularly affects
critically ill and immunocompromised patients (Sievert et al.
2013). This problem has been driven by the emergence and global
dissemination of successful lineages belonging to the hospital-
adapted E. faecium clade designated as A1 (previously known as
clonal complex 17 [CC17] by multilocus sequencing typing
[MLST]) (Willems et al. 2005; Arias and Murray 2013; Lebreton
et al. 2013; Guzman Prieto et al. 2016). Clade A1 isolates are char-
acterizedby chromosomallymediated ampicillin and fluoroquino-
lone resistance, high genomic plasticity, and the accumulation of
horizontally acquired genes encoding virulence factors and antibi-
otic resistance (Willems et al. 2001; Leavis et al. 2004, 2006;
Hegstad et al. 2010; Palmer et al. 2010). This includes resistance
to vancomycin, the drug of choice for ampicillin-resistant E. fae-
cium (AREfm) infection (Howden et al. 2013; Raven et al. 2017).
In contrast to cladeA1, ananimal-associated cladeA2andadistant-
ly related human commensal (or community-associated) clade B
are rarely associated with invasive infection or vancomycin resis-
tance (Lebreton et al. 2013; Raven et al. 2016).
Carriage of nosocomial pathogens precedes infection, and ef-
fective strategies to prevent infectionarebuilt on anunderstanding
of how and from where people acquire their infecting organism.
Genomic studies of nosocomial E. faecium infection have con-
firmed that transmission of E. faecium clade A1 is common
(Howden et al. 2013; Pinholt et al. 2017; Raven et al. 2017; van
Hal et al. 2017). A key unknown, however, is whether the develop-
ment of carrier status is solely attributable to acquisition in hospi-
tals or whether external reservoirs in the wider community and
Corresponding authors: sjp97@medschl.cam.ac.uk,
theo.gouliouris@doctors.org.uk
Article published online before print. Article, supplemental material, and publi-
cation date are at http://www.genome.org/cgi/doi/10.1101/gr.232629.117.
Freely available online through the Genome Research Open Access option.
© 2019 Gouliouris et al. This article, published inGenome Research, is available
under a Creative Commons License (Attribution 4.0 International), as described
at http://creativecommons.org/licenses/by/4.0/.
Research
626 Genome Research 29:626–634 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/19; www.genome.org
www.genome.org
 Cold Spring Harbor Laboratory Press on April 17, 2019 - Published by genome.cshlp.orgDownloaded from 
the environment could contribute to the background carriage rate.
There is also a lackof information regarding rates of VREfmcarriage
in community populations, including those receiving healthcare
and otherwise healthy populations. Municipal wastewater repre-
sents a surrogate reservoir containing pooled bacteria fromhuman
populations, the geographical spacing of which means that these
receive waste from a differing case-mix, including plants that
directly receive hospital waste and those that do not, in addition
to being located in urban and rural settings (Cai et al. 2014).
Here, we describe a study that aimed to usewastewater to gen-
erate indirect evidence for the extent to which healthcare-associat-
ed E. faecium is disseminated in the community. This took an
integrated approach that combinedmicrobiological, epidemiolog-
ical, and bacterial whole-genome sequence data and compared the
genetic relatedness and presence of antibiotic resistance and puta-
tive virulence genes in E. faecium from sewage and patients with
bloodstream infection in the same geographic region.
Results
Isolation of E. faecium from wastewater
A cross-sectional survey was conducted between June 2014 and
January 2015 to isolate and quantify E. faecium in untreated and
treated wastewater obtained from 20 municipal treatment plants
in the East of England, half of which were not in direct receipt of
hospital waste (Fig. 1A). Treated samples were obtained at the
point of release into surface waters. Ampicillin-resistant E. faecium
(a surrogatemarker for hospital-adapted lineages) and VREfmwere
isolated from untreated wastewater at all 20 plants. AREfm and
VREfmwere isolated from 18 and 17 treated samples, respectively,
the negative samples being from plants using terminal ultraviolet
light decontamination.
Wastewater treatment was associated with an average reduc-
tion incountof 3.0, 2.7, and2.5 log10 cfu/100mL for all enterococci,
AREfm, and VREfm, respectively (comparison of untreated versus
B C
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Figure 1. Geographic origin of E. faecium isolates and wastewater counts. (A) Map of 20 wastewater treatment plants in the East of England tested for E.
faecium, 10 of which were directly downstream from acute hospitals belonging to the Cambridge University Hospitals NHS Foundation Trust (CUH) referral
network. (WWP)Wastewater plant. Red dots indicate the source of bloodstream isolates. (Inset) Map of the United Kingdom, with square denoting the East
of England. (B) Log10 counts of E. faecium recovered from 100mL of wastewater under increasing antibiotic selection for untreated and treated wastewater
according to water treatment type: secondary (n=7), tertiary (n=10), UV light treatment (n=3), and for all plants (n=20). All comparisons between treat-
ed and untreatedwastewater counts were statistically significant (P<0.001), as were comparisons of count reductions according to treatment type for each
of total enterococci, AREfm, and VREfm (P=0.02, P<0.001, and P=0.001, respectively). (C ) Median log10 counts of E. faecium recovered from 100 mL of
wastewater under increasing antibiotic selection from untreated wastewater from the main CUH sewer on four separate occasions, from 10 wastewater
plants located downstream from acute hospitals, and from 10 wastewater plants unrelated to acute hospital waste. Boxes represent interquartile ranges,
whiskers 1.5 times the interquartile range, and dots outside values (B,C).
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treated wastewater, P<0.001 in all cases) (Fig. 1B). The median
count of VREfm in untreated and treated wastewater was 12,463
and 14 cfu/100 mL, respectively (P<0.001). The log10 reduction
was not dependent on E. faecium counts in untreated wastewater
but varied by treatment process. Thehighest level of treatment pro-
cesses used at the plants was secondary (n= 7), tertiary (n=10), or
terminal ultraviolet light decontamination (n=3) (see Supple-
mental Methods and Supplemental Table S1 for further details).
Compared with secondary treatment, tertiary treatment reduced
AREfm andVREfmby a further 0.8 and 0.7 log10 cfu/100mL on av-
erage, respectively. UV light reduced the concentration of AREfm
and VREfm by a further 2.4 and 2.0 log10 cfu/100 mL, respectively
(P<0.001 and 0.002, respectively).
Four sewage samples were also obtained for culture from the
main hospital sewer at the Cambridge University Hospitals NHS
Foundation Trust (CUH, a major teaching hospital in the East of
England) between September 2014 and December 2015. AREfm
and VREfm were isolated from all four samples. Bacterial counts
on selective agar for AREfm and VREfm were roughly equivalent
to the total enterococcal count on nonselective agar (median
log10 cfu/100 mL 5.9, 5.7, and 6.1, respectively) (Fig. 1C), indicat-
ing that drug-resistant E. faecium predominated. This contrasted
with untreated municipal wastewater, where the counts of
AREfm and VREfm were 5.7% (IQR 2.9%–14.5%) and 1.1% (IQR
0.4%–2.6%) of the counts of total enterococci, respectively
(Fig. 1B). Median log10 counts of AREfm and VREfm in 100 mL of
untreatedwastewater fromplants thatwere in direct receipt of hos-
pital sewage were significantly higher than plants that were not
(5.2 vs. 4.4, P<0.001, and 4.3 vs. 3.5, P=0.008, respectively), al-
though total enterococcal counts were not significantly different
(6.0 vs. 6.1, P=0.60) (Fig. 1C).
Comparing the genomes of E. faecium from wastewater
and invasive disease
We selected 423 E. faecium isolates for sequencing (383 from treat-
ment plants and 40 from the CUH sewer) (see Supplemental
Methods for further details of isolation and selection). In silico
MLST of the 383 isolates from treatment plants resolved 93 se-
quence types (STs), including28novel STs (including twoprevious-
ly nontypeable isolates due to the absence of pstS assigned to
ST1478) (Carter et al. 2016; Raven et al. 2016), indicating a high
genetic diversity (STs are listed in Supplemental Tables S2, S3).
E. faecium from nonselective agar was the most diverse (60 STs, 92
isolates, 0.65 ST/isolate), comparedwith29 STs forE. faecium select-
ed for ampicillin resistance (112 isolates, 0.26ST/isolate) and17STs
for E. faecium selected for vancomycin resistance (179 isolates, 0.09
ST/isolate) (Fig. 2A; SupplementalTableS3). In silicoMLSTof the40
isolates from the hospital sewer resolved 15 STs, the majority of
which were either ST18 (n=10) or ST80 (n =10) and included four
novel STs (Supplemental Table S2). These findings are consistent
with specific subsets of STs being associated with drug resistance.
B
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Figure 2. Genetic characterization of E. faecium isolates from wastewater and bloodstream infections. (A) MLST sequence types of 383 E. faecium isolates
recovered from wastewater according to antibiotic selection during isolation. Nonselective: no selection for antibiotic resistance; ampicillin: ampicillin-re-
sistance selection; vancomycin: vancomycin-resistance selection. (B) Midpoint rooted maximum-likelihood tree based on SNPs in 1336 core genes of 620
E. faecium (383 wastewater, 40 hospital sewage, 187 from bloodstream, and 10 reference isolates) labeled by hierarchical Bayesian cluster (1–7), clade
(B, A2, and A1), ampicillin-susceptibility, commonest STs, origin, and year of isolation. Scale bar, ∼10,000 SNPs. (C) Proportion of each E. faecium clade
recovered from wastewater according to antibiotic selection during isolation. A single isolate of clade A2 recovered on the vancomycin selective plate was
vancomycin-susceptible. Error bars, standard deviation.
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We then compared the genomes of the 423 wastewater
E. faecium isolates with 187 E. faecium isolates associated with
bloodstream infection in patients in the East of England between
2010 and 2016. Phylogenetic reconstruction using SNPs in the
core genome of these 610 isolates together with 10 nonstudy ge-
nomes from open access databases demonstrated that the popula-
tion divided into two major lineages, which were consistent with
clade B (43 isolates), and clade A (577 isolates) (Fig. 2B).
Hierarchical Bayesian clustering resolved seven BAPS (Bayesian
Analysis of Population Structure) groups, of which three corre-
sponded to clade B and four to clade A, the latter including BAPS-
2 corresponding to the ST17/18 lineage, BAPS-3 corresponding to
ST78, and BAPS-1 predominantly corresponding to ST80 (Fig. 2B).
BAPS-4 had several distinctive features, including genomes
that resided on long branches (indicating distantly related iso-
lates) and ampicillin-susceptible isolates (consistent with clade
A2). Furthermore, this BAPS group was paraphyletic (located in
two different positions in the tree). The distinction between A1
and A2 was resolved by constructing a phylogeny based on core
genome mapping to the Aus0004 strain (Lam et al. 2013) after ex-
cluding the most basal A2 isolates (designated A2.1) (Supple-
mental Fig. S1). These findings suggested that clade A2 was
heterogeneous and contained a lineage (designated here as A2.2)
that resided between A2.1 and A1, including AREfm isolates be-
longing to STs associated previously with carriage by domestic
dogs (e.g., ST19, ST192, ST266, ST401) (de Regt et al. 2012), al-
though distinct from other ST192 isolates that clearly resided in
clade A1. These findings are indicative of a highly dynamic
genome with recombination between lineages that have been
considered to have different associations (i.e., hospital- versus an-
imal-associated). Trees of clades A2 and B are shown in Supple-
mental Figure S2.
Having identified clades A1, A2, and B, we plotted each clade
against the three different culture media used for bacterial
isolation (Fig. 2C). This confirmed that ampicillin-susceptible
E. faecium resided in clades B and A2, AREfm resided in clades A2
and A1, and VREfm was exclusive to clade A1. We observed that
clade A2 isolates constituted approximately half of E. faecium in
untreated sewage. None of the plants knowingly received farm ef-
fluent, suggesting that these “animal-associated” lineages may be
commonly carried by people in the community. Hospital-adapted
lineages of clade A1were present in treatment plants in both urban
and rural settings and were not restricted to wastewater plants
downstream from hospitals.
We then focused our analysis on the 481 isolates in clade A1
to determine the comparative phylogeny and gene content be-
tween isolates from wastewater and patients with bloodstream in-
fection. A maximum-likelihood phylogeny following removal of
recombination and mobile elements showed a diverse population
interspersedwith clonal expansions (Fig. 3A). Numerous clonal ex-
pansions were noted, with closely related isolates shared between
two or more locations, including wastewater treatment plants (lo-
cated downstream and unrelated to hospitals), hospital sewage,
and/or invasive isolates. The largest cluster (termed C1) contained
72 isolates (15% of the total), including 64 from 15/20 wastewater
treatment plants, four from CUH sewage, and four bloodstream
isolates from CUH in 2014–15. The majority of isolates (68/72)
in this cluster belonged to ST80. The substitution rate of the
branch leading to this large cluster (calculated based on isolates
shown in red in Fig. 3A) was 9.21 SNP/genome/yr (3.23× 10−6
BA
Figure 3. Distribution of clade A1 E. faecium and clonal expansion of dominant clusters. (A) Maximum-likelihood tree based on SNPs in the core genes of
481 clade A1 E. faecium isolates colored by geographical location in relation to receipt of hospital sewage, origin, wastewater plant location in relation to
hospitals, treated or untreated wastewater, and presence of van genes. Branch leading to and including the dominant cluster is colored in red. Scale bar,
∼55 SNPs. (B) Phylogenetic network analysis showing relatedness of E. faecium based on place of origin displayed as shapes corresponding to geographical
coordinates. Circles: wastewater treatment plants located downstream from hospitals; squares: wastewater treatment plants unrelated to hospital waste;
star: Cambridge University Hospitals (bloodstream isolates). The edges (lines) link isolates that were very closely related (within 5 SNPs in the core
genome).
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SNPs/site/yr), estimating the most recent common ancestor of C1
and related isolates at ∼9.4 yr (95% highest posterior density
[HPD], 7.6–11.8 yr), with 83/91 (91%) having diverged 4.9 yr ago
(95% HPD, 4.1–5.9 yr) (Fig. 4). This suggests their recent emer-
gence and dissemination in our geographic region, including iso-
lates that caused invasive disease.
Themajority of wastewater treatment plants each contained a
genetically diverse E. faecium cladeA1populationbased on core ge-
nomepairwise SNPdistance (Supplemental Fig. S3a). This diversity
was comparable to the diversity reported for isolates associated
with bloodstream infection from across the United Kingdom
(Raven et al. 2016) and was not affected by the treatment process
(medianSNPdistance251 vs. 242 in rawand treatedwastewater, re-
spectively, P=0.54) (Supplemental Fig. S3b). In contrast, the min-
imum SNP distance between untreated and treated wastewater
samples was zero for 14 of 18 evaluable locations (range 0–10),
suggesting persistence of some strains at eachplant following treat-
ment (Supplemental Fig. S3c). Closely related isolates were also
detected between different wastewater treatment plants (Supple-
mental Fig. S3d).
Comparison of relatedness between E. faecium fromwastewa-
ter and bloodstream infection showed that the minimum SNP dis-
tance between any bloodstream towastewater isolate did not differ
significantly for plants located downstream from hospitals versus
plants unrelated to hospitals (median 35 vs. 46, P=0.09) (Supple-
mental Fig. S3e). Network analysis using a strict 5-SNP cut-off (con-
sistent with less than 1 yr of evolution based on this study and
previous estimates [Raven et al. 2017]) revealed geographical clus-
tering of wastewater treatment plants. Bloodstream isolates from
CUH formed a direct network with 9/20 plants (three unrelated
to hospital waste), indicating recent dissemination of invasive
and wastewater E. faecium across the region (Fig. 3B).
Genes encoding antibiotic resistance and virulence
Having established close genetic relatedness between isolates from
different reservoirs and locations based on the core genome,we ana-
lyzed thepangenomeofcladeA1isolates for thepresenceofantibiot-
ic, metal, and biocide resistance genes (Fig. 5A,B). Of 28 different
resistancegenesdetected,23(82%)were represented inbloodstream,
hospital sewage, and municipal wastewater isolates. Municipal
wastewater isolates harbored the greatest diversity, including spw,
cat(pC221), tet(40), and cueO that confer spectinomycin, chloram-
phenicol, tetracycline, and copper resistance, respectively, which
wereexclusivetowastewaterisolates(Fig.5C,top).Therewere197dif-
ferent antibiotic resistance gene combinations, with only three pro-
files shared between all three reservoirs and greater diversity
detected in wastewater (Fig. 5C, bottom). The median number of
genes detected was 9 (interquartile range [IQR] 8–10), 9 (IQR 9–11),
and 8 (IQR 7–11) for bloodstream, hospital sewage, and municipal
wastewater isolates, respectively. An analysis of putative virulence
genes led us to detect 32 genes that were present inwastewater, hos-
pital sewage, and bloodstream isolates (Supplemental Fig. S4). No
gene was exclusively present in wastewater or bloodstream isolates
based on a pangenome analysis (Supplemental Fig. S5).
We investigated the genetic context of the vanA transposon
for 108 isolates belonging to the lineage leading to the dominant
cluster C1 investigated above, of which 80 contained the vanA
gene (see Methods). Ninety-four isolates had reads mapping at
>80% (65 at >90%) to a completely sequenced plasmid from a
dominant clinical cluster of bloodstream isolates circulating in
CUH since 2007 (Raven et al. 2017) that contained a novel rep
gene and two genes encoding putative cell-surface proteins with
Cna protein B-type domains but no additional resistance genes.
Absence of vanA genes was associated either with loss of this
plasmid or with loss of the vanA transpo-
son and an approximately 9.5-kb down-
stream region flanked by IS1216E (Fig. 6).
Discussion
This systematic genomic survey of
E. faecium in wastewater indicates that
hospital-adapted lineages of VREfm are
widespread in wastewater across the East
of England, adding to previous studies re-
stricted to wastewater collected down-
stream from hospitals (Novais et al.
2005; Caplin et al. 2008; Leclercq et al.
2013; Varela et al. 2013). Wastewater
treatment did not prevent downstream
environmental contamination with
these lineages,with themajorityofplants
releasing drug-resistant E. faecium into
the environment. Stronger controls are
required to prevent these organisms be-
ing freely released into the water system.
Ultraviolet light was used at three study
plants and was effective in decontami-
nating wastewater prior to release. This
represents a ready solution thatwould re-
duce environmental contaminationwith
VREfm and drug-resistant bacteria more
generally.
Figure 4. Timeline of emergence of dominant E. faecium cluster. Maximum clade credibility tree of
branch leading to and including the dominant cluster from BEAST analysis (n=108 isolates). Branch in
red includes all isolates of cluster (and neighboring isolates). Blue bars indicate 95% highest probability
density (HPD) values. (Right) Circles denote origin of isolates. Green: wastewater; purple: CUH sewage;
red: bloodstream infection. Time bar (yr) shown at the bottom.
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The use of culture media containing incremental antibiotic
selective pressure allowed us to sample the diversity of E. faecium
and quantify and obtain sufficient numbers of resistant lineages
that were present in wastewater as a minority of the overall popu-
lation. The observation that AREfmandVREfm countswere higher
in untreated wastewater from plants in direct receipt of hospital
sewage versus those that were not is predictable and consistent
with the finding that the relative proportion of VREfm inwastewa-
ter from the CUH hospital main sewer was high. However, the
detection of VREfm at all treatment plants is an important finding
and consistent with widespread dissemination of drug-resistant
lineages in the community. Potential reservoirs include people
with past or on-going healthcare contact, including hospital pa-
tients and those in long-term care facilities (Brodrick et al. 2016).
Given the scale of VREfm detection, including from plants in rural
areas, it is possible that VREfm carriage extends to the wider
healthy population. This could include healthcare workers, family
contacts of people receiving healthcare, and people with no direct
or indirect healthcare-associated contact. Potential sources in the
wider community include the environment and the food chain.
There is a lack of data on rates of VREfm carriage by healthy pop-
ulations, with recent data from our group suggesting that VREfm
in the food chain differs genetically from human and wastewater
VREfm (Gouliouris et al. 2018). Further systematic studies are
needed to identify community carriage.
Whole-genome sequence-based comparison of E. faecium
fromwastewater and patients with significant infection is essential
for the accurate determination of relatedness between bacteria
from disease and nondisease reservoirs. The core genome phylog-
enies generated here demonstrated that these were genetically in-
termixed and detected numerous highly related clusters that
contained isolates from patients and wastewater. Wastewater iso-
lates from nine treatment plants (including those that did not
receive hospital sewage) were closely related to E. faecium associat-
ed with bloodstream infection at CUH. Furthermore, isolates from
patients and nonhuman sources shared the majority of antibiotic
resistance and virulence genes investigated. These observations
build on our culture-based findings and provide strong evidence
for the widespread dissemination of highly related healthcare-as-
sociated drug-resistant E. faecium lineages.
In conclusion, our findings highlight the challenges of con-
trolling healthcare-associated dissemination of VREfm. The extent
to which isolates from humans and wastewater were related indi-
cates that wastewater could be used for the surveillance of circulat-
ingVREfmlineages.The riskposed tohumanhealth fromextensive
release of VREfm into the environment is uncertain but could be
controlled by improving wastewater decontamination both at the
hospital and municipal waste level. Both the risk of release and
the benefit derived from preventing this require further study.
Methods
Wastewater sampling and microbiology
We performed a cross-sectional survey of 20municipal wastewater
treatment plants in the East of England between June 2014 and
A
C
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Figure 5. Distribution of antimicrobial resistance genes in hospital-adapted E. faecium from bloodstream infections, hospital, and municipal sewage.
(A) Presence of antibiotic, metal, and biocide resistance genes grouped by antibiotic family in clade A1 E. faecium isolates shown against the core SNPmax-
imum likelihood tree (left-hand side). Colors in left-hand columns correspond to those in Figure 3. Antimicrobial resistance gene columns: green, present;
white, absent. (B) Frequency of detection of each gene in wastewater, hospital sewage, and bloodstream isolates (green: wastewater; purple: hospital
sewer; red: bloodstream). (C) Venn diagrams showing the degree of overlap between individual and combined resistance gene profiles in the three res-
ervoirs. (Upper panel) Innermost circle: bloodstream; middle circle: hospital sewer; outer circle: wastewater.
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January 2015. Ten plants directly received sewage from acute NHS
Hospital Trusts (median distance between plant and respective
hospital: 5.3 km [range 3.3–9.6 km] downstream), and 10 plants
did not directly receive hospital sewage. Treatment plant charac-
teristics are shown in Supplemental Table S1 and described in Sup-
plemental Methods. In brief, all plants processed wastewater using
primary treatment (sedimentation of large particles in primary set-
tlement tanks) and secondary treatment, which consisted of acti-
vated sludge and/or biological trickling filter beds. Ten plants
utilized an additional tertiary step, such as lagooning (reed beds)
or sand filtration. Wastewater effluent from three plants with dis-
charge into sensitive coastal waters (shellfish production areas)
was disinfected by a terminal ultraviolet light step. Untreated
and treated wastewater were obtained from each plant. Grab sam-
ples of 0.5 L were collected at each sampling point and mixed into
1 L sterile bottles containing 18 mg sodium thiosulphate (Sigma-
Aldrich). Additional sampling was performed at the hospital sewer
(main septic tank) of CUH, when a single 1 L wastewater sample
was obtained at four spaced time points between September
2014 and December 2015.
Bacterial quantification in wastewater was achieved by the
membrane filtration method adapted from previously described
protocols (Figueras et al. 2000) using the EZ-Stream vacuum
pump and EZ-Fit Manifold system (Merck Millipore). Membranes
were placed onto Slanetz-Bartley (SB) agar (Oxoid); ampicillin-
selective medium BBL Enterococcosel agar (BD) supplemented
with 30 mg/L ampicillin (Sigma-Aldrich); and vancomycin-selec-
tive medium Brilliance VRE chromogenic agar (Oxoid). Bacteria
were identified to the species level using matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry (MALDI-
TOF MS; Biotyper version 3.1, Bruker Daltonics). Antimicrobial
susceptibility testing was determined using the P607 card on the
VITEK2 instrument (bioMérieux) (Supplemental Fig. S6). More de-
tails of sample processing are provided in Supplemental Methods.
Bacteria for genome sequencing
Up to 20 colonies (isolates) were selected from primary cultures
from each plant for genome sequencing (equal numbers from un-
treated and treated wastewater). Final selectionwas based on diver-
sity of antibiotic resistance patterns (100 of the 110 possible
patterns were included), whichwe used as a rough surrogate for ge-
netic diversity. A further 10 isolates were selected from each CUH
sewer sample using the same criteria. In all, 428wastewater isolates
were sequenced (388 from treatment plants and 40 fromCUH sew-
ers), of which five were subsequently excluded based on sequence
quality metrics. Supplemental Table S2 provides the details of
origin and isolation year for each isolate. The clinical isolate
collection used here contained 187 E. faecium associated with
bloodstream infection in 187 patients, as follows: 140 patients at
Figure 6. Reads mapped against vanA reference plasmid EC503 showing common plasmid backbone present in bloodstream and wastewater isolates.
Left-hand side: maximum-likelihood tree of branch leading to dominant clade (n=108). Scale bar, 23 SNPs. The density of the horizontal bars corresponds
to the read coverage, with black indicating presence and white absence. (Top) Turquoise arrows, coding sequences: pink, vanA transposon genes; orange,
IS1216E; purple, novel repB_1 gene; brown, genes encoding for novel putative cell-surface proteins (Cna protein B-type domains) and associated sortases.
Markings shown at 20,000 bp. Vancomycin susceptibility was associated with lack of plasmid or lack of vanA transposon (with or without downstream 3′
region). Full sequence and annotation files of plasmid EC503 are available in Supplemental File S2.
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CUH between 2010–2012, 24 patients at four further hospitals in
the East of England between 2010–2012, and 23 consecutive cases
of E. faecium bacteremia in hematology patients at CUH between
May 2014 and April 2016. Isolates from 2010–2012 had already
been sequenced, and data were downloaded from the Wellcome
Sanger Institute. The remainder were sequenced as part of this pro-
ject. DNA extraction and library preparation were performed as
previously described (Raven et al. 2017). DNA libraries were se-
quenced using the Illumina HiSeq platform (Illumina Inc.).
Further details can be found in Supplemental Methods.
Phylogenetic analyses
A phylogenetic analysis was undertaken combining 620 genomes
(423 wastewater, 187 clinical, and 10 nonstudy publicly available
complete E. faecium genomes (see Supplemental Table S2 for acces-
sionnumbers). Genomeswere aligned to define a core and accesso-
ry genome using Roary (Page et al. 2015). The resulting alignment
of 100,136 core single nucleotide polymorphisms (SNPs) was used
to create a phylogeny with RAxML (Stamatakis 2014) and to pro-
duce a tree-independent hierarchical Bayesian clustering with
hierBAPS (Cheng et al. 2013). Further details are provided in the
Supplemental Methods. Multilocus sequence typing was deter-
mined from genome assemblies using MLST Check (Page et al.
2016)with novel alleles and STs deposited in the pubMLSTwebsite
(https://pubmlst.org/efaecium/). Absence of the pstS gene in two
isolates was confirmed by SRST2 (Inouye et al. 2014).
Thehospital-adapted lineage (A1)wasdefined byphylogenet-
ic methods (see Supplemental Methods for details) and a phyloge-
netic tree of 481 genomes created using RAxML based onmapping
to the Aus0004 genome (ENA accession number CP003351).
Pairwise SNPdistanceswere calculated from the core genomeusing
a custom script available as Supplemental Code, and at https://
github.com/simonrharris/pairwise_difference_count. Timeline re-
construction of the largest cluster was performed using BEAST
v1.8.2 (Drummond et al. 2012), as described in the Supplemental
Methods.
Analysis of antimicrobial resistance, virulence genes, and plasmids
Acquired genes encoding antimicrobial resistance were detected
using amanually curated and updated version of the ResFinder da-
tabase (compiled in 2012) (Zankari et al. 2012; additional genes are
listed in Supplemental Table S4). A database of putative virulence
genes was created based on E. faecium genes from the Virulence
Factor Database (VFDB) (http://www.mgc.ac.cn/cgi-bin/VFs/
genus.cgi?Genus=Enterococcus) (Chen et al. 2016) and supple-
mented after a literature review (Supplemental Table S5). The
raw genomic reads were queried for resistance and virulence genes
using Antibiotic Resistance Identification by Assembly (ARIBA)
v2.5.0 (https://github.com/sanger-pathogens/ariba) (Hunt et al.
2017) with default length and match thresholds of 95% and
90%, respectively. Further processing of the output data is de-
scribed in the Supplemental Methods. Plasmid analysis was per-
formed using plasmidSPAdes (Antipov et al. 2016) and BLASTN,
with details provided in the Supplemental Methods.
Statistical analyses were performed using STATA v13.1
(StataCorp LLC), as described in Supplemental Methods.
Ethical approval
The study protocol was approved by the CUH Research and
Development Department (ref: A093285) and the National
Research Ethics Service East of England Ethics Committee (ref:
12/EE/0439 and 14/EE/1123).
Data access
Sequence data from this study have been submitted to the
European Nucleotide Archive (ENA; www.ebi.ac.uk/ena) under
the accession numbers listed in Supplemental Table S2. The
MATLAB script described in Supplemental Methods is available
in Supplemental File S1.
Competing interest statement
J.P. and S.J.P. are paid consultants to Next GenDiagnostics. S.J.P. is
a consultant to Specific.
Acknowledgments
We thank the staff at the wastewater treatment plants and at
Cambridge University Hospitals Estates Department for assistance
in sample collection. We also thank the library construction, se-
quencing, and core informatics teams at the Wellcome Trust
Sanger Institute for assistancewith Illumina sequencing. This pub-
lication presents independent research supported by the Health
Innovation Challenge Fund (WT098600, HICF-T5-342), a parallel
funding partnership between the Department of Health and
Wellcome Trust. The views expressed in this publication are those
of the author(s) and not necessarily those of the Department of
Health or Wellcome Trust. This work was supported by a
Wellcome Trust Research Training Fellowship (to T.G. [103387/Z/
13/Z]), a Wellcome Trust Sir Henry Postdoctoral Fellowship (to
C.L. [110243/Z/15/Z] and F.C. [201344/Z/16/Z]), and an ERC grant
(742158) (to J.C.).
References
Antipov D, Hartwick N, Shen M, Raiko M, Lapidus A, Pevzner PA. 2016.
plasmidSPAdes: assembling plasmids from whole genome sequencing
data. Bioinformatics 32: 3380–3387. doi:10.1093/bioinformatics/
btw493
Arias CA,Murray BE. 2013. The rise of the Enterococcus: beyond vancomycin
resistance. Nat Rev Microbiol 10: 266–278. doi:10.1038/nrmicro2761
Brodrick HJ, Raven KE, Harrison EM, Blane B, Reuter S, TörökME, Parkhill J,
Peacock SJ. 2016. Whole-genome sequencing reveals transmission of
vancomycin-resistant Enterococcus faecium in a healthcare network.
Genome Med 8: 4. doi:10.1186/s13073-015-0259-7
Cai L, Ju F, Zhang T. 2014. Tracking human sewage microbiome in amunic-
ipal wastewater treatment plant. Appl Microbiol Biotechnol 98: 3317–
3326. doi:10.1007/s00253-013-5402-z
Caplin JL, Hanlon GW, Taylor HD. 2008. Presence of vancomycin and am-
picillin-resistant Enterococcus faecium of epidemic clonal complex-17 in
wastewaters from the south coast of England. Environ Microbiol 10: 885–
892. doi:10.1111/j.1462-2920.2007.01507.x
Carter GP, Buultjens AH, Ballard SA, Baines SL, Tomita T, Strachan J,
Johnson PDR, Ferguson JK, Seemann T, Stinear TP, et al. 2016.
Emergence of endemic MLST non-typeable vancomycin-resistant
Enterococcus faecium. J Antimicrob Chemother 71: 3367–3371. doi:10
.1093/jac/dkw314
Chen L, Zheng D, Liu B, Yang J, Jin Q. 2016. VFDB 2016: hierarchical and
refined dataset for big data analysis—10 years on. Nucleic Acids Res 44:
D694–D697. doi:10.1093/nar/gkv1239
Cheng L, Connor TR, Siren J, Aanensen DM, Corander J. 2013. Hierarchical
and spatially explicit clustering of DNA sequences with BAPS software.
Mol Biol Evol 30: 1224–1228. doi:10.1093/molbev/mst028
de RegtMJA, van SchaikW, van Luit-AsbroekM,Dekker HAT, vanDuijkeren
E, Koning CJM, Bonten MJM,Willems RJL. 2012. Hospital and commu-
nity ampicillin-resistant Enterococcus faecium are evolutionarily closely
linked but have diversified through niche adaptation. PLoS One 7:
e30319. doi:10.1371/journal.pone.0030319
Drummond AJ, Suchard MA, Xie D, Rambaut A. 2012. Bayesian phyloge-
netics with BEAUti and the BEAST 1.7. Mol Biol Evol 29: 1969–1973.
doi:10.1093/molbev/mss075
Figueras MJ, Borrego J, Pike EB, Robertson W, Ashbolt N. 2000. Sanitary in-
spection andmicrobiological water quality. InMonitoring bathing waters:
a practical guide to the design and implementation of assessments and
Vancomycin-resistant E. faecium in wastewater
Genome Research 633
www.genome.org
 Cold Spring Harbor Laboratory Press on April 17, 2019 - Published by genome.cshlp.orgDownloaded from 
monitoring programmes (ed. Bartram J, Rees G), Chap. 8. World Health
Organization, New York.
Gouliouris T, Raven KE, Ludden C, Blane B, Corander J, Horner CS,
Hernandez-Garcia J, Wood P, Hadjirin NF, Radakovic M, et al. 2018.
Genomic surveillance of Enterococcus faecium reveals limited sharing
of strains and resistance genes between livestock and humans in the
United Kingdom. mBio 9: e01780-18. doi:10.1128/mBio.01780-18
Guzman Prieto AM, van Schaik W, Rogers MRC, Coque TM, Baquero F,
Corander J, Willems RJL. 2016. Global emergence and dissemination
of enterococci as nosocomial pathogens: attack of the clones? Front
Microbiol 7: 788. doi:10.3389/fmicb.2016.00788
Hegstad K, Mikalsen T, Coque TM, Werner G, Sundsfjord A. 2010. Mobile
genetic elements and their contribution to the emergence of antimicro-
bial resistant Enterococcus faecalis and Enterococcus faecium.ClinMicrobiol
Infect 16: 541–554. doi:10.1111/j.1469-0691.2010.03226.x
Howden BP, Holt KE, LamMMC, Seemann T, Ballard S, Coombs GW, Tong
SYC, Grayson ML, Johnson PDR, Stinear TP. 2013. Genomic insights to
control the emergence of vancomycin-resistant enterococci. mBio 4:
e00412-13. doi:10.1128/mBio.00412-13
HuntM,Mather AE, Sánchez-Busó L, Page AJ, Parkhill J, Keane JA, Harris SR.
2017. ARIBA: rapid antimicrobial resistance genotyping directly from
sequencing reads. Microb Genom 3: e000131. doi:10.1099/mgen.0
.000131
Inouye M, Dashnow H, Raven L-A, Schultz MB, Pope BJ, Tomita T, Zobel J,
Holt KE. 2014. SRST2: rapid genomic surveillance for public health and
hospitalmicrobiology labs.GenomeMed6: 90. doi:10.1186/s13073-014-
0090-6
Lam MMC, Seemann T, Tobias NJ, Chen H, Haring V, Moore RJ, Ballard S,
Grayson LM, Johnson PDR, Howden BP, et al. 2013. Comparative anal-
ysis of the complete genome of an epidemic hospital sequence type 203
clone of vancomycin-resistant Enterococcus faecium. BMC Genomics 14:
595. doi:10.1186/1471-2164-14-595
Leavis H, Top J, Shankar N, Borgen K, Bonten M, van Embden J, Willems
RJL. 2004. A novel putative enterococcal pathogenicity island linked
to the esp virulence gene of Enterococcus faecium and associated with ep-
idemicity. J Bacteriol 186: 672–682. doi:10.1128/JB.186.3.672-682.2004
Leavis HL, Willems RJL, Top J, Bonten MJM. 2006. High-level ciprofloxacin
resistance from point mutations in gyrA and parC confined to global
hospital-adapted clonal lineage CC17 of Enterococcus faecium. J Clin
Microbiol 44: 1059–1064. doi:10.1128/JCM.44.3.1059-1064.2006
Lebreton F, van Schaik W, McGuire AM, Godfrey P, Griggs A, Corander J,
Cheng L, Saif S, Young S, Zeng Q, et al. 2013. Emergence of epidemic
multidrug-resistant Enterococcus faecium from animal and commensal
strains. mBio 4: e00534-13. doi:10.1128/mBio.00534-13
Leclercq R, Oberlé K, Galopin S, Cattoir V, Budzinski H, Petit F. 2013.
Changes in enterococcal populations and related antibiotic resistance
along a medical center-wastewater treatment plant-river continuum.
Appl Environ Microbiol 79: 2428–2434. doi:10.1128/AEM.03586-12
Novais C, Coque TM, FerreiraH, Sousa C, Peixe L. 2005. Environmental con-
tamination with vancomycin-resistant enterococci from hospital sew-
age in Portugal. Appl Environ Microbiol 71: 3364–3368. doi:10.1128/
AEM.71.6.3364-3368.2005
Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MTG, Fookes
M, Falush D, Keane JA, Parkhill J. 2015. Roary: rapid large-scale prokary-
ote pan genome analysis. Bioinformatics 31: 3691–3693. doi:10.1093/
bioinformatics/btv421
Page AJ, Taylor B, Keane JA. 2016. Multilocus sequence typing by blast from
de novo assemblies against PubMLST. J Open Source Softw 1: 118. doi:10
.21105/joss.00118
Palmer KL, Kos VN, Gilmore MS. 2010. Horizontal gene transfer and the ge-
nomics of enterococcal antibiotic resistance. Curr Opin Microbiol 13:
632–639. doi:10.1016/j.mib.2010.08.004
Pinholt M, Gumpert H, Bayliss S, Nielsen JB, Vorobieva V, Pedersen M, Feil
E, Worning P, Westh H. 2017. Genomic analysis of 495 vancomycin-
resistant Enterococcus faecium reveals broad dissemination of a vanA plas-
mid in more than 19 clones from Copenhagen, Denmark. J Antimicrob
Chemother 72: 40–47. doi:10.1093/jac/dkw360
Raven KE, Reuter S, Reynolds R, Brodrick HJ, Russell JE, TörökME, Parkhill J,
Peacock SJ. 2016. A decade of genomic history for healthcare-associated
Enterococcus faecium in theUnited Kingdom and Ireland.Genome Res26:
1388–1396. doi:10.1101/gr.204024.116
Raven KE, Gouliouris T, Brodrick H, Coll F, BrownNM, Reynolds R, Reuter S,
Török ME, Parkhill J, Peacock SJ. 2017. Complex routes of nosocomial
vancomycin-resistant Enterococcus faecium transmission revealed by ge-
nome sequencing. Clin Infect Dis 64: 15–17. doi:10.1093/cid/ciw872
Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A,
Limbago B, Fridkin S. 2013. Antimicrobial-resistant pathogens associat-
ed with healthcare-associated infections: summary of data reported to
the National Healthcare Safety Network at the Centers for Disease
Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 34:
1–14. doi:10.1086/668770
Stamatakis A. 2014. RAxML version 8: a tool for phylogenetic analysis and
post-analysis of large phylogenies. Bioinformatics 30: 1312–1313. doi:10
.1093/bioinformatics/btu033
van Hal SJ, Espedido BA, Coombs GW, Howden BP, Korman TM, Nimmo
GR, Gosbell IB, Jensen SO. 2017. Polyclonal emergence of vanA vanco-
mycin-resistant Enterococcus faecium in Australia. J Antimicrob Chemother
72: 998–1001. doi:10.1093/jac/dkw539
Varela AR, Ferro G, Vredenburg J, Yanık M, Vieira L, Rizzo L, Lameiras C,
Manaia CM. 2013. Vancomycin resistant enterococci: from the hospital
effluent to the urban wastewater treatment plant. Sci Total Environ 450–
451: 155–161. doi:10.1016/j.scitotenv.2013.02.015
Willems RJL, Homan W, Top J, van Santen-Verheuvel M, Tribe D,
Manzioros X, Gaillard C, Vandenbroucke-Grauls CMJE, Mascini EM,
van Kregten E, et al. 2001. Variant esp gene as a marker of a distinct ge-
netic lineage of vancomycin-resistant Enterococcus faecium spreading in
hospitals. Lancet 357: 853–855. doi:10.1016/S0140-6736(00)04205-7
Willems RJL, Top J, van Santen M, Robinson DA, Coque TM, Baquero F,
Grundmann H, BontenMJM. 2005. Global spread of vancomycin-resis-
tant Enterococcus faecium from distinct nosocomial genetic complex.
Emerg Infect Dis 11: 821–828. doi:10.3201/1106.041204
Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O,
Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobi-
al resistance genes. J Antimicrob Chemother 67: 2640–2644. doi:10.1093/
jac/dks261
Received November 22, 2017; accepted in revised form February 14, 2019.
Gouliouris et al.
634 Genome Research
www.genome.org
 Cold Spring Harbor Laboratory Press on April 17, 2019 - Published by genome.cshlp.orgDownloaded from 
 10.1101/gr.232629.117Access the most recent version at doi:
2019 29: 626-634 originally published online March 21, 2019Genome Res. 
  
Theodore Gouliouris, Kathy E. Raven, Danesh Moradigaravand, et al. 
  
indicates widespread distribution and release into the environment
plantshospital-adapted lineages in municipal wastewater treatment 
Enterococcus faeciumDetection of vancomycin-resistant 
  
Material
Supplemental
  
 http://genome.cshlp.org/content/suppl/2019/03/15/gr.232629.117.DC1
  
References
  
 http://genome.cshlp.org/content/29/4/626.full.html#ref-list-1
This article cites 35 articles, 8 of which can be accessed free at:
  
Open Access
  
 Open Access option.Genome ResearchFreely available online through the 
  
License
Commons 
Creative
.http://creativecommons.org/licenses/by/4.0/
Commons License (Attribution 4.0 International), as described at 
, is available under a CreativeGenome ResearchThis article, published in 
Service
Email Alerting
  
 click here.top right corner of the article or 
Receive free email alerts when new articles cite this article - sign up in the box at the
 http://genome.cshlp.org/subscriptions
go to: Genome Research To subscribe to 
© 2019 Gouliouris et al.; Published by Cold Spring Harbor Laboratory Press
 Cold Spring Harbor Laboratory Press on April 17, 2019 - Published by genome.cshlp.orgDownloaded from 
